Patent assignee · US · COMPANY

Agenus Inc.

🏢 View company profile →
52Patents
52Active
52Granted
54Portfolio score

Filing activity: Sep 13, 2004 → Dec 20, 2023 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US10280226B2 Anti-GITR antibodies and methods of use thereof Emerging Cross-Sectional Technologies 14 Active
US10155818B2 Anti-GITR antibodies and methods of use thereof Emerging Cross-Sectional Technologies 14 Active
US8541002B2 Vaccine for treatment and prevention of herpes simplex virus infection Chemistry; Metallurgy 13 Active
US10259882B2 Anti-OX40 antibodies Physics 11 Active
US10639368B2 Anti-TIM-3 antibodies and methods of use thereof Chemistry; Metallurgy 10 Active
US10836830B2 Antibodies and methods of use thereof Chemistry; Metallurgy 9 Active
US10144779B2 Anti-CTLA-4 antibodies and methods of use thereof Chemistry; Metallurgy 5 Active
US10626181B2 Nucleic acids encoding anti-OX40 antibodies Physics 5 Active
US10479833B2 Anti-CTLA-4 antibodies and methods of use thereof Chemistry; Metallurgy 4 Active
US10912831B1 Anti-CTLA-4 antibodies and methods of use thereof Emerging Cross-Sectional Technologies 4 Active
US10323091B2 Anti-PD-1 antibodies and methods of use thereof Chemistry; Metallurgy 3 Active
US10577426B2 Anti-GITR antibodies and methods of use thereof Emerging Cross-Sectional Technologies 3 Active
US11013802B2 Anti-CTLA-4 antibodies and methods of use thereof Emerging Cross-Sectional Technologies 3 Active
US10800849B2 Anti-GITR antibodies and methods of use thereof Emerging Cross-Sectional Technologies 2 Active
US10844119B2 Anti-LAG-3 antibodies and methods of use thereof Chemistry; Metallurgy 2 Active
US10640535B2 Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies Chemistry; Metallurgy 2 Active
US10912828B2 Anti-TIM-3 antibodies and methods of use thereof Chemistry; Metallurgy 2 Active
US10882908B2 Anti-LAG-3 antibodies and methods of use thereof Chemistry; Metallurgy 2 Active
US11638755B2 Anti-CTLA-4 antibodies and methods of use thereof Emerging Cross-Sectional Technologies 1 Active
US11053315B2 Anti-ILT4 antibodies and antigen-binding fragments Chemistry; Metallurgy 1 Active
US10829559B2 Anti-GITR antibodies and methods of use thereof Physics 1 Active
US11345755B2 Anti-PD-1 antibodies and methods of use thereof Chemistry; Metallurgy 1 Active
US11021537B2 Anti-TIGIT antibodies and methods of use thereof Emerging Cross-Sectional Technologies 1 Active
US9593327B2 Identification of antigen or ligand-specific binding proteins Chemistry; Metallurgy 1 Active
US11692042B2 Anti-CD73 antibodies and methods of use thereof Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.